Core Viewpoint - The document outlines the management system for the deferral and exemption of information disclosure by Renzi Hang Network Technology Co., Ltd, aiming to ensure compliance with legal obligations and protect investors' rights [1][2]. Group 1: General Principles - The purpose of the system is to regulate the deferral and exemption of information disclosure, ensuring that the company and related parties fulfill their disclosure obligations in accordance with relevant laws and regulations [1]. - The system applies to situations where information disclosure can be deferred or exempted as per the requirements of the China Securities Regulatory Commission and the Shenzhen Stock Exchange [2]. Group 2: Scope of Deferral and Exemption - Information can be exempted from disclosure if it involves state secrets or other matters that may violate confidentiality regulations [5]. - The company has an obligation to protect state secrets and must not disclose sensitive information through any means, including investor interactions or media releases [6]. - Commercial secrets can also be deferred or exempted from disclosure if they meet specific criteria, such as potential harm to competitive advantage or violation of others' commercial secrets [7]. Group 3: Internal Management Procedures - The company must carefully determine the need for deferral or exemption and follow internal review procedures before implementation [12]. - The board of directors leads the management of deferral and exemption matters, with the board secretary responsible for organizing and coordinating these activities [13]. - A formal application and approval process is established, requiring relevant departments to submit a request for deferral or exemption, which must be reviewed and approved by the board [14][15]. Group 4: Disclosure Obligations - If the reasons for deferral or exemption are no longer valid, the company must promptly disclose the information [8]. - The company must report any deferred or exempted information in its annual, semi-annual, or quarterly reports within ten days after the report is published [18]. Group 5: Accountability and Enforcement - The company has established a mechanism for accountability regarding deferral and exemption practices, holding responsible parties accountable for any improper handling of disclosure matters [19]. - The system must comply with the rules of the Shenzhen Stock Exchange and other relevant regulations [20].

Core Viewpoint - The document outlines the regulations and procedures for Zhejiang Fulai New Materials Co., Ltd. regarding the deferral and exemption of information disclosure, emphasizing the importance of compliance with legal obligations to protect investors' rights [1][2]. Group 1: General Provisions - The company and other information disclosers must comply with the laws and regulations regarding information disclosure, ensuring that disclosures are truthful, accurate, complete, timely, and fair [1][2]. - Information disclosers include the company, its directors, senior management, shareholders, actual controllers, acquirers, and other relevant parties [1]. Group 2: Scope of Deferral and Exemption - Information that is legally recognized as state secrets or involves commercial secrets may be exempted from disclosure if it could harm national security or violate confidentiality laws [2][3]. - Commercial secrets are defined as non-public information that can bring economic benefits and has been kept confidential by the rights holder [2]. Group 3: Management of Deferral and Exemption - Information that is deferred or exempted must meet specific conditions, including that the information has not been leaked and that insiders have committed to confidentiality [3][4]. - The company can use alternative methods such as pseudonyms or summaries to protect sensitive information in periodic reports [4]. Group 4: Procedures and Responsibilities - The board of directors is responsible for overseeing the deferral and exemption of disclosures, with the secretary of the board coordinating the process [5][6]. - Any deferral or exemption must be documented, including the type of information and the internal review process [5][6]. Group 5: Reporting and Compliance - The company must report any deferred or exempted information to the relevant regulatory bodies within ten days after the publication of periodic reports [6][7]. - Failure to comply with the disclosure requirements may result in disciplinary actions against responsible personnel [6][7].

Core Viewpoint - The article outlines the information disclosure deferral and exemption management system of Zhejiang Lino Fluid Control Technology Co., Ltd, emphasizing the need for compliance with legal obligations and the protection of investors' rights [1][2]. Group 1: General Principles - The system aims to regulate the deferral and exemption of information disclosure by the company and other obligated parties, ensuring compliance with relevant laws and regulations [1]. - Information disclosure obligations must be fulfilled truthfully, accurately, completely, timely, and fairly, without misuse of deferral or exemption to mislead investors [2]. Group 2: Conditions for Deferral and Exemption - Deferral or exemption from disclosure is permitted if the information involves state secrets or could violate confidentiality regulations [2]. - Business secrets can be deferred or exempted if disclosure could lead to unfair competition or harm the interests of the company or others [2][3]. Group 3: Internal Review Procedures - The company must carefully determine the need for deferral or exemption and follow internal review procedures to prevent unauthorized disclosure [4][5]. - The board of directors oversees the management of deferral and exemption matters, with the board secretary responsible for coordinating these activities [4]. Group 4: Registration and Reporting - The company must maintain a record of deferred or exempted disclosures, including the type of information and the reasons for deferral or exemption [5][6]. - Relevant materials must be submitted to the regulatory authorities within ten days after the announcement of periodic reports [6]. Group 5: Accountability and Compliance - The company must not abuse the deferral or exemption procedures and will hold responsible parties accountable for any violations that negatively impact the company or investors [6][7]. - The management system must comply with the rules of the Shenzhen Stock Exchange and other relevant regulations [8].

Core Viewpoint - The company, Baotou Huazi Industrial Co., Ltd., is set to hold an annual performance briefing for 2024 and the first quarter of 2025 on June 17, 2025, to address investor inquiries and discuss financial results [2][3][4]. Group 1: Performance Briefing Details - The performance briefing will take place on June 17, 2025, from 10:00 to 11:00 AM at the Shanghai Stock Exchange Roadshow Center [2][4]. - Investors can submit questions from June 10 to June 16, 2025, through the Roadshow Center website or via the company's email [2][5]. - The company aims to provide insights into its operational results and financial status for 2024 and Q1 2025 during the briefing [3][4]. Group 2: Board Meeting Resolutions - The company's board of directors convened on June 9, 2025, and all resolutions were passed unanimously [10][12]. - The board approved a guarantee of 9 million RMB for three wholly-owned subsidiaries to secure loans of 3 million RMB each for operational needs [15][25]. - The board also revised the "Information Disclosure Postponement and Exemption Management System" to enhance compliance with disclosure obligations [17][18]. Group 3: Guarantee Details - The total guarantee amount for the subsidiaries is 9 million RMB, with no collateral provided by the subsidiaries [22][25]. - The guarantee is intended to support the subsidiaries' borrowing needs without adversely affecting the company's operations [35]. - As of the announcement date, the company has no overdue external guarantees, and the total external guarantee balance is 29 million RMB, representing 1.77% of the latest audited net assets [35].

Core Viewpoint - The document outlines the information disclosure deferral and exemption management system for Huamao (Xiamen) New Materials Technology Co., Ltd, aiming to regulate the company's disclosure obligations and protect investors' rights [1][2]. Group 1: General Principles - The system is established to standardize the deferral and exemption of information disclosure by the company and related parties, ensuring compliance with relevant laws and regulations [1]. - The company must carefully determine deferral and exemption matters and follow internal review procedures before implementation [2]. Group 2: Scope of Deferral and Exemption - Information that involves state secrets or commercial secrets can be exempted from disclosure if it meets specific criteria, such as potential harm to the company or others' interests [2][3]. - If the reasons for deferral or exemption are eliminated, or if the information becomes difficult to keep confidential, timely disclosure is required [3]. Group 3: Internal Management of Deferral and Exemption - The company must document the decision to defer or exempt disclosure, including the method of exemption and the type of documents involved [4]. - Relevant materials regarding deferral or exemption must be submitted to the Xiamen Securities Regulatory Bureau and the Shanghai Stock Exchange within ten days after the announcement of periodic reports [4][5]. Group 4: Miscellaneous Provisions - Any matters not covered by this system will be executed according to relevant laws and regulations, and the board of directors is responsible for the formulation, modification, and interpretation of this system [5].

Core Viewpoint - The document outlines the management system for the temporary suspension and exemption of information disclosure by Shenzhen Qiangrui Precision Technology Co., Ltd, emphasizing compliance with relevant laws and regulations to protect investors' rights [1][2]. Group 1: General Principles - The purpose of the system is to standardize the temporary suspension and exemption of information disclosure, ensuring compliance with the Securities Law of the People's Republic of China and other relevant regulations [1]. - The system applies to situations where information disclosure can be temporarily suspended or exempted based on specific legal and regulatory conditions [1][2]. Group 2: Scope of Suspension and Exemption - Information can be exempted from disclosure if it involves state secrets or other matters that may violate confidentiality regulations [2]. - Companies have an obligation to protect state secrets and must not disclose sensitive information through any means, including investor interactions and media releases [2]. - Commercial secrets can also be temporarily suspended or exempted from disclosure if they meet certain criteria, such as potential harm to competitive advantage or violation of others' commercial secrets [2][3]. Group 3: Internal Management Procedures - The company must ensure accurate, complete, and timely information disclosure and cannot misuse the suspension or exemption to evade disclosure obligations [4]. - The board of directors is responsible for overseeing the management of suspension and exemption matters, with the board secretary coordinating the process [4][5]. - A formal application process is established for requesting suspension or exemption, requiring documentation and approval from relevant authorities within the company [5][6]. Group 4: Accountability and Compliance - The company has a mechanism for accountability regarding the suspension and exemption of disclosures, with potential consequences for those who fail to comply with the established procedures [6]. - If the reasons for suspension or exemption are resolved, the company must promptly disclose the relevant information and the circumstances surrounding the initial decision [6][7].

三生国健: 三生国健：信息披露暂缓与豁免管理制 度 信息披露暂缓与豁免管理制度 三生国健药业（上海）股份有限公司 信息披露暂缓与豁免管理制度 第一章 总则 第一条 为了进一步规范三生国健药业（上海）股份有限公司（以 下简称"公司"）信息披露暂缓、豁免行为，督促公司及相关信息披露 义务人（以下简称"信息披露义务人"）依法合规地履行信息披露义务， 根据《中华人民共和国证券法》《上海证券交易所科创板股票上市规则》 （以下简称"《科创板上市规则》"）、《上海证券交易所科创板上市公司 自律监管指引第 1 号——规范运作》（以下简称"《规范运作指引》" ）等 相关法律法规和规范性文件以及《三生国健药业（上海）股份有限公司 章程》（以下简称"《公司章程》"）的相关规定，并结合公司实际情况， 制定本制度。 第二条 信息披露义务人按照《科创板上市规则》《规范运作指引》 及其他相关法律法规、规范性文件的规定，办理信息披露暂缓、豁免业 务的，适用本制度。 第三条 信息披露义务人应当披露的信息存在《科创板上市规则》 《规范运作指引》及上海证券交易所其他相关业务规则中规定的可暂缓、 豁免信息披露的情形的，可以无须向上海证券交易所申请， ...